The deficiency of OPG genes resulted in severe osteoporosis in both human and experimental animals [15,16], while systemic administration of rhOPG prevented osteopenia and ovariectomy-induced bone loss [1,14,15]. The gene discussed is TNFRSF11B; the disease is osteoporosis.